Report Detail

Pharma & Healthcare Asia-Pacific Nuclear Receptor ROR-Gamma Market Report 2018

  • RnM1774859
  • |
  • 21 March, 2018
  • |
  • Global
  • |
  • 119 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

In this report, the Asia-Pacific Nuclear Receptor ROR-Gamma market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Nuclear Receptor ROR-Gamma for these regions, from 2013 to 2025 (forecast), including
China
Japan
South Korea
Taiwan
India
Southeast Asia
Australia

Asia-Pacific Nuclear Receptor ROR-Gamma market competition by top manufacturers/players, with Nuclear Receptor ROR-Gamma sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
4SC AG
Advinus Therapeutics Ltd.
Arrien Pharmaceuticals, LLC
Aurigene Discovery Technologies Limited
Biogen, Inc.
Brickell Biotech, Inc.
Bristol-Myers Squibb Company
Celgene Corporation
Genentech, Inc.
Genfit SA
GlaxoSmithKline Plc
Hanmi Pharmaceuticals, Co. Ltd.
Karo Bio AB
Lead Pharma Holding B.V.
Nuevolution AB
Phenex Pharmaceuticals AG
Reata Pharmaceuticals, Inc.
Teijin Pharma Limited
Visionary Pharmaceuticals, Inc.
Vitae Pharmaceuticals, Inc.

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
VPR-66
INV-17
GSK-2981278
BBI-6000
Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospital
Clinic
Others

If you have any special requirements, please let us know and we will offer you the report as you want.


Table of Contents

    Asia-Pacific Nuclear Receptor ROR-Gamma Market Report 2018

      1 Nuclear Receptor ROR-Gamma Overview

      • 1.1 Product Overview and Scope of Nuclear Receptor ROR-Gamma
      • 1.2 Classification of Nuclear Receptor ROR-Gamma by Product Category
        • 1.2.1 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size (Sales) Comparison by Types (2013-2025)
        • 1.2.2 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size (Sales) Market Share by Type (Product Category) in 2017
        • 1.2.3 VPR-66
        • 1.2.4 INV-17
        • 1.2.5 GSK-2981278
        • 1.2.6 BBI-6000
        • 1.2.7 Others
      • 1.3 Asia-Pacific Nuclear Receptor ROR-Gamma Market by Application/End Users
        • 1.3.1 Asia-Pacific Nuclear Receptor ROR-Gamma Sales (Volume) and Market Share Comparison by Applications (2013-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
        • 1.3.4 Others
      • 1.4 Asia-Pacific Nuclear Receptor ROR-Gamma Market by Region
        • 1.4.1 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size (Value) Comparison by Region (2013-2025)
        • 1.4.2 China Status and Prospect (2013-2025)
        • 1.4.3 Japan Status and Prospect (2013-2025)
        • 1.4.4 South Korea Status and Prospect (2013-2025)
        • 1.4.5 Taiwan Status and Prospect (2013-2025)
        • 1.4.6 India Status and Prospect (2013-2025)
        • 1.4.7 Southeast Asia Status and Prospect (2013-2025)
        • 1.4.8 Australia Status and Prospect (2013-2025)
      • 1.5 Asia-Pacific Market Size (Value and Volume) of Nuclear Receptor ROR-Gamma (2013-2025)
        • 1.5.1 Asia-Pacific Nuclear Receptor ROR-Gamma Sales and Growth Rate (2013-2025)
        • 1.5.2 Asia-Pacific Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2013-2025)

      2 Asia-Pacific Nuclear Receptor ROR-Gamma Competition by Players/Suppliers, Region, Type and Application

      • 2.1 Asia-Pacific Nuclear Receptor ROR-Gamma Market Competition by Players/Suppliers
        • 2.1.1 Asia-Pacific Nuclear Receptor ROR-Gamma Sales Volume and Market Share of Key Players/Suppliers (2013-2018)
        • 2.1.2 Asia-Pacific Nuclear Receptor ROR-Gamma Revenue and Share by Players/Suppliers (2013-2018)
      • 2.2 Asia-Pacific Nuclear Receptor ROR-Gamma (Volume and Value) by Type
        • 2.2.1 Asia-Pacific Nuclear Receptor ROR-Gamma Sales and Market Share by Type (2013-2018)
        • 2.2.2 Asia-Pacific Nuclear Receptor ROR-Gamma Revenue and Market Share by Type (2013-2018)
      • 2.3 Asia-Pacific Nuclear Receptor ROR-Gamma (Volume) by Application
      • 2.4 Asia-Pacific Nuclear Receptor ROR-Gamma (Volume and Value) by Region
        • 2.4.1 Asia-Pacific Nuclear Receptor ROR-Gamma Sales and Market Share by Region (2013-2018)
        • 2.4.2 Asia-Pacific Nuclear Receptor ROR-Gamma Revenue and Market Share by Region (2013-2018)

      3 China Nuclear Receptor ROR-Gamma (Volume, Value and Sales Price)

      • 3.1 China Nuclear Receptor ROR-Gamma Sales and Value (2013-2018)
        • 3.1.1 China Nuclear Receptor ROR-Gamma Sales Volume and Growth Rate (2013-2018)
        • 3.1.2 China Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2013-2018)
        • 3.1.3 China Nuclear Receptor ROR-Gamma Sales Price Trend (2013-2018)
      • 3.2 China Nuclear Receptor ROR-Gamma Sales Volume and Market Share by Type
      • 3.3 China Nuclear Receptor ROR-Gamma Sales Volume and Market Share by Application

      4 Japan Nuclear Receptor ROR-Gamma (Volume, Value and Sales Price)

      • 4.1 Japan Nuclear Receptor ROR-Gamma Sales and Value (2013-2018)
        • 4.1.1 Japan Nuclear Receptor ROR-Gamma Sales Volume and Growth Rate (2013-2018)
        • 4.1.2 Japan Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2013-2018)
        • 4.1.3 Japan Nuclear Receptor ROR-Gamma Sales Price Trend (2013-2018)
      • 4.2 Japan Nuclear Receptor ROR-Gamma Sales Volume and Market Share by Type
      • 4.3 Japan Nuclear Receptor ROR-Gamma Sales Volume and Market Share by Application

      5 South Korea Nuclear Receptor ROR-Gamma (Volume, Value and Sales Price)

      • 5.1 South Korea Nuclear Receptor ROR-Gamma Sales and Value (2013-2018)
        • 5.1.1 South Korea Nuclear Receptor ROR-Gamma Sales Volume and Growth Rate (2013-2018)
        • 5.1.2 South Korea Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2013-2018)
        • 5.1.3 South Korea Nuclear Receptor ROR-Gamma Sales Price Trend (2013-2018)
      • 5.2 South Korea Nuclear Receptor ROR-Gamma Sales Volume and Market Share by Type
      • 5.3 South Korea Nuclear Receptor ROR-Gamma Sales Volume and Market Share by Application

      6 Taiwan Nuclear Receptor ROR-Gamma (Volume, Value and Sales Price)

      • 6.1 Taiwan Nuclear Receptor ROR-Gamma Sales and Value (2013-2018)
        • 6.1.1 Taiwan Nuclear Receptor ROR-Gamma Sales Volume and Growth Rate (2013-2018)
        • 6.1.2 Taiwan Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2013-2018)
        • 6.1.3 Taiwan Nuclear Receptor ROR-Gamma Sales Price Trend (2013-2018)
      • 6.2 Taiwan Nuclear Receptor ROR-Gamma Sales Volume and Market Share by Type
      • 6.3 Taiwan Nuclear Receptor ROR-Gamma Sales Volume and Market Share by Application

      7 India Nuclear Receptor ROR-Gamma (Volume, Value and Sales Price)

      • 7.1 India Nuclear Receptor ROR-Gamma Sales and Value (2013-2018)
        • 7.1.1 India Nuclear Receptor ROR-Gamma Sales Volume and Growth Rate (2013-2018)
        • 7.1.2 India Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2013-2018)
        • 7.1.3 India Nuclear Receptor ROR-Gamma Sales Price Trend (2013-2018)
      • 7.2 India Nuclear Receptor ROR-Gamma Sales Volume and Market Share by Type
      • 7.3 India Nuclear Receptor ROR-Gamma Sales Volume and Market Share by Application

      8 Southeast Asia Nuclear Receptor ROR-Gamma (Volume, Value and Sales Price)

      • 8.1 Southeast Asia Nuclear Receptor ROR-Gamma Sales and Value (2013-2018)
        • 8.1.1 Southeast Asia Nuclear Receptor ROR-Gamma Sales Volume and Growth Rate (2013-2018)
        • 8.1.2 Southeast Asia Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2013-2018)
        • 8.1.3 Southeast Asia Nuclear Receptor ROR-Gamma Sales Price Trend (2013-2018)
      • 8.2 Southeast Asia Nuclear Receptor ROR-Gamma Sales Volume and Market Share by Type
      • 8.3 Southeast Asia Nuclear Receptor ROR-Gamma Sales Volume and Market Share by Application

      9 Australia Nuclear Receptor ROR-Gamma (Volume, Value and Sales Price)

      • 9.1 Australia Nuclear Receptor ROR-Gamma Sales and Value (2013-2018)
        • 9.1.1 Australia Nuclear Receptor ROR-Gamma Sales Volume and Growth Rate (2013-2018)
        • 9.1.2 Australia Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2013-2018)
        • 9.1.3 Australia Nuclear Receptor ROR-Gamma Sales Price Trend (2013-2018)
      • 9.2 Australia Nuclear Receptor ROR-Gamma Sales Volume and Market Share by Type
      • 9.3 Australia Nuclear Receptor ROR-Gamma Sales Volume and Market Share by Application

      10 Asia-Pacific Nuclear Receptor ROR-Gamma Players/Suppliers Profiles and Sales Data

      • 10.1 4SC AG
        • 10.1.1 Company Basic Information, Manufacturing Base and Competitors
        • 10.1.2 Nuclear Receptor ROR-Gamma Product Category, Application and Specification
          • 10.1.2.1 Product A
          • 10.1.2.2 Product B
        • 10.1.3 4SC AG Nuclear Receptor ROR-Gamma Sales, Revenue, Price and Gross Margin (2013-2018)
        • 10.1.4 Main Business/Business Overview
      • 10.2 Advinus Therapeutics Ltd.
        • 10.2.1 Company Basic Information, Manufacturing Base and Competitors
        • 10.2.2 Nuclear Receptor ROR-Gamma Product Category, Application and Specification
          • 10.2.2.1 Product A
          • 10.2.2.2 Product B
        • 10.2.3 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Sales, Revenue, Price and Gross Margin (2013-2018)
        • 10.2.4 Main Business/Business Overview
      • 10.3 Arrien Pharmaceuticals, LLC
        • 10.3.1 Company Basic Information, Manufacturing Base and Competitors
        • 10.3.2 Nuclear Receptor ROR-Gamma Product Category, Application and Specification
          • 10.3.2.1 Product A
          • 10.3.2.2 Product B
        • 10.3.3 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Sales, Revenue, Price and Gross Margin (2013-2018)
        • 10.3.4 Main Business/Business Overview
      • 10.4 Aurigene Discovery Technologies Limited
        • 10.4.1 Company Basic Information, Manufacturing Base and Competitors
        • 10.4.2 Nuclear Receptor ROR-Gamma Product Category, Application and Specification
          • 10.4.2.1 Product A
          • 10.4.2.2 Product B
        • 10.4.3 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Sales, Revenue, Price and Gross Margin (2013-2018)
        • 10.4.4 Main Business/Business Overview
      • 10.5 Biogen, Inc.
        • 10.5.1 Company Basic Information, Manufacturing Base and Competitors
        • 10.5.2 Nuclear Receptor ROR-Gamma Product Category, Application and Specification
          • 10.5.2.1 Product A
          • 10.5.2.2 Product B
        • 10.5.3 Biogen, Inc. Nuclear Receptor ROR-Gamma Sales, Revenue, Price and Gross Margin (2013-2018)
        • 10.5.4 Main Business/Business Overview
      • 10.6 Brickell Biotech, Inc.
        • 10.6.1 Company Basic Information, Manufacturing Base and Competitors
        • 10.6.2 Nuclear Receptor ROR-Gamma Product Category, Application and Specification
          • 10.6.2.1 Product A
          • 10.6.2.2 Product B
        • 10.6.3 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Sales, Revenue, Price and Gross Margin (2013-2018)
        • 10.6.4 Main Business/Business Overview
      • 10.7 Bristol-Myers Squibb Company
        • 10.7.1 Company Basic Information, Manufacturing Base and Competitors
        • 10.7.2 Nuclear Receptor ROR-Gamma Product Category, Application and Specification
          • 10.7.2.1 Product A
          • 10.7.2.2 Product B
        • 10.7.3 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Sales, Revenue, Price and Gross Margin (2013-2018)
        • 10.7.4 Main Business/Business Overview
      • 10.8 Celgene Corporation
        • 10.8.1 Company Basic Information, Manufacturing Base and Competitors
        • 10.8.2 Nuclear Receptor ROR-Gamma Product Category, Application and Specification
          • 10.8.2.1 Product A
          • 10.8.2.2 Product B
        • 10.8.3 Celgene Corporation Nuclear Receptor ROR-Gamma Sales, Revenue, Price and Gross Margin (2013-2018)
        • 10.8.4 Main Business/Business Overview
      • 10.9 Genentech, Inc.
        • 10.9.1 Company Basic Information, Manufacturing Base and Competitors
        • 10.9.2 Nuclear Receptor ROR-Gamma Product Category, Application and Specification
          • 10.9.2.1 Product A
          • 10.9.2.2 Product B
        • 10.9.3 Genentech, Inc. Nuclear Receptor ROR-Gamma Sales, Revenue, Price and Gross Margin (2013-2018)
        • 10.9.4 Main Business/Business Overview
      • 10.10 Genfit SA
        • 10.10.1 Company Basic Information, Manufacturing Base and Competitors
        • 10.10.2 Nuclear Receptor ROR-Gamma Product Category, Application and Specification
          • 10.10.2.1 Product A
          • 10.10.2.2 Product B
        • 10.10.3 Genfit SA Nuclear Receptor ROR-Gamma Sales, Revenue, Price and Gross Margin (2013-2018)
        • 10.10.4 Main Business/Business Overview
      • 10.11 GlaxoSmithKline Plc
      • 10.12 Hanmi Pharmaceuticals, Co. Ltd.
      • 10.13 Karo Bio AB
      • 10.14 Lead Pharma Holding B.V.
      • 10.15 Nuevolution AB
      • 10.16 Phenex Pharmaceuticals AG
      • 10.17 Reata Pharmaceuticals, Inc.
      • 10.18 Teijin Pharma Limited
      • 10.19 Visionary Pharmaceuticals, Inc.
      • 10.20 Vitae Pharmaceuticals, Inc.

      11 Nuclear Receptor ROR-Gamma Manufacturing Cost Analysis

      • 11.1 Nuclear Receptor ROR-Gamma Key Raw Materials Analysis
        • 11.1.1 Key Raw Materials
        • 11.1.2 Price Trend of Key Raw Materials
        • 11.1.3 Key Suppliers of Raw Materials
        • 11.1.4 Market Concentration Rate of Raw Materials
      • 11.2 Proportion of Manufacturing Cost Structure
        • 11.2.1 Raw Materials
        • 11.2.2 Labor Cost
        • 11.2.3 Manufacturing Expenses
      • 11.3 Manufacturing Process Analysis of Nuclear Receptor ROR-Gamma

      12 Industrial Chain, Sourcing Strategy and Downstream Buyers

      • 12.1 Nuclear Receptor ROR-Gamma Industrial Chain Analysis
      • 12.2 Upstream Raw Materials Sourcing
      • 12.3 Raw Materials Sources of Nuclear Receptor ROR-Gamma Major Manufacturers in 2017
      • 12.4 Downstream Buyers

      13 Marketing Strategy Analysis, Distributors/Traders

      • 13.1 Marketing Channel
        • 13.1.1 Direct Marketing
        • 13.1.2 Indirect Marketing
        • 13.1.3 Marketing Channel Development Trend
      • 13.2 Market Positioning
        • 13.2.1 Pricing Strategy
        • 13.2.2 Brand Strategy
        • 13.2.3 Target Client
      • 13.3 Distributors/Traders List

      14 Market Effect Factors Analysis

      • 14.1 Technology Progress/Risk
        • 14.1.1 Substitutes Threat
        • 14.1.2 Technology Progress in Related Industry
      • 14.2 Consumer Needs/Customer Preference Change
      • 14.3 Economic/Political Environmental Change

      15 Asia-Pacific Nuclear Receptor ROR-Gamma Market Forecast (2018-2025)

      • 15.1 Asia-Pacific Nuclear Receptor ROR-Gamma Sales Volume, Revenue and Price Forecast (2018-2025)
        • 15.1.1 Asia-Pacific Nuclear Receptor ROR-Gamma Sales Volume and Growth Rate Forecast (2018-2025)
        • 15.1.2 Asia-Pacific Nuclear Receptor ROR-Gamma Revenue and Growth Rate Forecast (2018-2025)
        • 15.1.3 Asia-Pacific Nuclear Receptor ROR-Gamma Price and Trend Forecast (2018-2025)
      • 15.2 Asia-Pacific Nuclear Receptor ROR-Gamma Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
        • 15.2.1 Asia-Pacific Nuclear Receptor ROR-Gamma Sales Volume and Growth Rate Forecast by Region (2018-2025)
        • 15.2.2 Asia-Pacific Nuclear Receptor ROR-Gamma Revenue and Growth Rate Forecast by Region (2018-2025)
        • 15.2.3 China Nuclear Receptor ROR-Gamma Sales, Revenue and Growth Rate Forecast (2018-2025)
        • 15.2.4 Japan Nuclear Receptor ROR-Gamma Sales, Revenue and Growth Rate Forecast (2018-2025)
        • 15.2.5 South Korea Nuclear Receptor ROR-Gamma Sales, Revenue and Growth Rate Forecast (2018-2025)
        • 15.2.6 Taiwan Nuclear Receptor ROR-Gamma Sales, Revenue and Growth Rate Forecast (2018-2025)
        • 15.2.7 India Nuclear Receptor ROR-Gamma Sales, Revenue and Growth Rate Forecast (2018-2025)
        • 15.2.8 Southeast Asia Nuclear Receptor ROR-Gamma Sales, Revenue and Growth Rate Forecast (2018-2025)
        • 15.2.9 Australia Nuclear Receptor ROR-Gamma Sales, Revenue and Growth Rate Forecast (2018-2025)
      • 15.3 Asia-Pacific Nuclear Receptor ROR-Gamma Sales, Revenue and Price Forecast by Type (2018-2025)
        • 15.3.1 Asia-Pacific Nuclear Receptor ROR-Gamma Sales Forecast by Type (2018-2025)
        • 15.3.2 Asia-Pacific Nuclear Receptor ROR-Gamma Revenue Forecast by Type (2018-2025)
        • 15.3.3 Asia-Pacific Nuclear Receptor ROR-Gamma Price Forecast by Type (2018-2025)
      • 15.4 Asia-Pacific Nuclear Receptor ROR-Gamma Sales Forecast by Application (2018-2025)

      16 Research Findings and Conclusion

        17 Appendix

        • 17.1 Methodology/Research Approach
          • 17.1.1 Research Programs/Design
          • 17.1.2 Market Size Estimation
          • 17.1.3 Market Breakdown and Data Triangulation
        • 17.2 Data Source
          • 17.2.1 Secondary Sources
          • 17.2.2 Primary Sources

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $4,000.00
        $8,000.00
        3,196.00
        6,392.00
        3,732.00
        7,464.00
        622,200.00
        1,244,400.00
        333,320.00
        666,640.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report